-
Behavioral Health Barometer: Region 10, Volume 7: Indicators as Measured in the 2021-2022 National Surveys on Drug Use and Health [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2024 Apr.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Health Technology Assessment, No. 28.73.
Harnan S, Kearns B, Scope A, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Oct.
-
Identifying and Treating Childhood Hearing Loss in Rural Alaska -- The Hearing Norton Sound Study [Internet].
Robler SK, Platt A, Turner EL, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2022 Feb.
-
Impact of Drug Shortages on Patients in the United States: A Case Study of Three Drugs: ASPE Report [Internet].
Beleche T, Adetunji O, Parasrampuria S, et al.
Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2024 Apr.
-
Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review [Internet].
Comparative Effectiveness Review, No. 273.
Parikh RR, Troester A, Southwell B, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Aug.
See more...
Image credit: SEM Penicillium mold and spores; David Gregory and Debbie Marshall, Wellcome Images